The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Generalisability in economic evaluation studies in healthcare: a review and case studies
Open accessAbstract
OBJECTIVES: To review, and to develop further, the methods used to assess and to increase the generalisability of economic evaluation studies. DATA SOURCES: Electronic databases. REVIEW METHODS: Methodological studies relating to economic evaluation in healthcare were searched. This included electronic searches of a range of databases, including PREMEDLINE, MEDLINE, EMBASE and EconLit, and manual searches of key journals. The case studies of a decision analytic model involved highlighting specific features of previously published economic studies related to generalisability and location-related variability. The case-study involving the secondary analysis of cost-effectiveness analyses was based on the secondary analysis of three economic studies using data from randomised trials. RESULTS: The factor most frequently cited as generating variability in economic results between locations was the unit costs associated with particular resources. In the context of studies based on the analysis of patient-level data, regression analysis has been advocated as a means of looking at variability in economic results across locations. These methods have generally accepted that some components of resource use and outcomes are exchangeable across locations. Recent studies have also explored, in cost-effectiveness analysis, the use of tests of heterogeneity similar to those used in clinical evaluation in trials. The decision analytic model has been the main means by which cost-effectiveness has been adapted from trial to non-trial locations. Most models have focused on changes to the cost side of the analysis, but it is clear that the effectiveness side may also need to be adapted between locations. There have been weaknesses in some aspects of the reporting in applied cost-effectiveness studies. These may limit decision-makers' ability to judge the relevance of a study to their specific situations. The case study demonstrated the potential value of multilevel modelling (MLM). Where clustering exists by location (e.g. centre or country), MLM can facilitate correct estimates of the uncertainty in cost-effectiveness results, and also a means of estimating location-specific cost-effectiveness. The review of applied economic studies based on decision analytic models showed that few studies were explicit about their target decision-maker(s)/jurisdictions. The studies in the review generally made more effort to ensure that their cost inputs were specific to their target jurisdiction than their effectiveness parameters. Standard sensitivity analysis was the main way of dealing with uncertainty in the models, although few studies looked explicitly at variability between locations. The modelling case study illustrated how effectiveness and cost data can be made location-specific. In particular, on the effectiveness side, the example showed the separation of location-specific baseline events and pooled estimates of relative treatment effect, where the latter are assumed exchangeable across locations. CONCLUSIONS: A large number of factors are mentioned in the literature that might be expected to generate variation in the cost-effectiveness of healthcare interventions across locations. Several papers have demonstrated differences in the volume and cost of resource use between locations, but few studies have looked at variability in outcomes. In applied trial-based cost-effectiveness studies, few studies provide sufficient evidence for decision-makers to establish the relevance or to adjust the results of the study to their location of interest. Very few studies utilised statistical methods formally to assess the variability in results between locations. In applied economic studies based on decision models, most studies either stated their target decision-maker/jurisdiction or provided sufficient information from which this could be inferred. There was a greater tendency to ensure that cost inputs were specific to the target jurisdiction than clinical parameters. Methods to assess generalisability and variability in economic evaluation studies have been discussed extensively in the literature relating to both trial-based and modelling studies. Regression-based methods are likely to offer a systematic approach to quantifying variability in patient-level data. In particular, MLM has the potential to facilitate estimates of cost-effectiveness, which both reflect the variation in costs and outcomes between locations and also enable the consistency of cost-effectiveness estimates between locations to be assessed directly. Decision analytic models will retain an important role in adapting the results of cost-effectiveness studies between locations. Recommendations for further research include: the development of methods of evidence synthesis which model the exchangeability of data across locations and allow for the additional uncertainty in this process; assessment of alternative approaches to specifying multilevel models to the analysis of
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sample Selection Bias as a Specification Error
Heckman, J. J. (1979) · Econometrica · doi:10.2307/1912352 · Cited by 28,779
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Self-citationCost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
The National Institute for Clinical Excellence
(2001) · Nursing Management · doi:10.7748/nm.8.2.39.s15 · Cited by 3,876
Naylor, M. D., Brooten, D., Campbell, R., Jacobsen, B. S., Mezey, M. D., Pauly, M. V., & Schwartz, J. S. (1999) · JAMA · doi:10.1001/jama.281.7.613 · Cited by 1,831
Packer, M., Poole-Wilson, P. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Rydén, L., Thygesen, K., & Uretsky, B. F. (1999) · Circulation · doi:10.1161/01.cir.100.23.2312 · Cited by 1,244
Boersma, E., Harrington, R. A., Moliterno, D. J., White, H., Théroux, P., Van de Werf, F., de Torbal, A., Armstrong, P. W., Wallentin, L. C., Wilcox, R. G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07442-1 · Cited by 991
Fox, K., Poole-Wilson, P., Henderson, R., Clayton, T., Chamberlain, D., Shaw, T., Wheatley, D., & Pocock, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09894-x · Cited by 901
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-874_2 · Cited by 779
Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002092 · Cited by 751
Dealing With Medical Practice Variations: A Proposal for Action
Wennberg, J. E. (1984) · Health Affairs · doi:10.1377/hlthaff.3.2.6 · Cited by 712
Context, composition and heterogeneity: using multilevel models in health research
Duncan, C., Jones, K., & Moon, G. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00148-2 · Cited by 689
Serruys, P. W., van Hout, B., Bonnier, H., Legrand, V., Garcia, E., Macaya, C., Sousa, E., van der Giessen, W., Colombo, A., Seabra-Gomes, R., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11128-x · Cited by 650
The Treatment of Acute Low Back Pain — Bed Rest, Exercises, or Ordinary Activity?
Malmivaara, A., Häkkinen, U., Aro, T., Heinrichs, M.-L., Koskenniemi, L., Kuosma, E., Lappi, S., Paloheimo, R., Servo, C., Vaaranen, V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502093320602 · Cited by 615
Development of WHO guidelines on generalized cost-effectiveness analysis
Murray, C. J. L., Evans, D. B., Acharya, A., & Baltussen, R. M. P. M. (2000) · Health Economics · doi:10.1002/(sici)1099-1050(200004)9:3<235::aid-hec502>3.0.co;2-o · Cited by 577
Hoch, J. S., Briggs, A. H., & Willan, A. R. (2002) · Health Economics · doi:10.1002/hec.678 · Cited by 535
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Self-citationMark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322106 · Cited by 521
Venning, P. (2000) · BMJ · doi:10.1136/bmj.320.7241.1048 · Cited by 494
Briggs, A. H., Goeree, R., Blackhouse, G., & O'Brien, B. J. (2002) · Medical Decision Making · doi:10.1177/027298902400448867 · Cited by 414
A review of the use of health status measures in economic evaluation.
Brazier, Deverill, Green, Harper, & Booth (1999) · Health Technology Assessment · doi:10.3310/hta3090 · Cited by 413
An economic approach to clinical trial design and research priority-setting
Claxton, K., & Posnett, J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · Cited by 395
Handling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Sweat, M., Gregorich, S., Sangiwa, G., Furlonge, C., Balmer, D., Kamenga, C., Grinstead, O., & Coates, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02447-8 · Cited by 384
Statistical assessment of the learning curves of health technologies
Ramsay, C. R., Grant, A. M., Wallace, S. A., Garthwaite, P. H., Monk, A. F., & Russell, I. T. (2001) · Health Technology Assessment · doi:10.3310/hta5120 · Cited by 353
Decision Making in Health and Medicine: Integrating Evidence and Values
Ulahannan, T. J. (2002) · Journal of the Royal Society of Medicine · doi:10.1177/014107680209500220 · Cited by 338
MCCLELLAN, M., MCNEIL, B. J., & NEWHOUSE, J. P. (1995) · Survey of Anesthesiology · doi:10.1097/00132586-199506000-00003 · Cited by 331
Health Economic Guidelines—Similarities, Differences and Some Implications
Hjelmgren, J., Berggren, F., & Andersson, F. (2001) · Value in Health · doi:10.1046/j.1524-4733.2001.43040.x · Cited by 322
Garry, R., Fountain, J., Brown, J., Manca, A., Mason, S., Sculpher, M., Napp, V, Bridgman, S., Gray, J., & Lilford, R. (2004) · Health Technology Assessment · doi:10.3310/hta8260 · Cited by 300
Self-citationCampbell, M. K., Mollison, J., & Grimshaw, J. M. (2001) · Statistics in Medicine · doi:10.1002/1097-0258(20010215)20:3<391::aid-sim800>3.0.co;2-z · Cited by 299
Simon, G. E. (1996) · JAMA · doi:10.1001/jama.275.24.1897 · Cited by 294
On the decision rules of cost-effectiveness analysis
Johannesson, M., & Weinstein, M. C. (1993) · Journal of Health Economics · doi:10.1016/0167-6296(93)90005-y · Cited by 288
Grines, C. L., Marsalese, D. L., Brodie, B., Griffin, J., Donohue, B., Costantini, C. R., Balestrini, C., Stone, G., Wharton, T., Esente, P., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00031-x · Cited by 276
The black box of health care expenditure growth determinants
Barros, P. P. (1998) · Health Economics · doi:10.1002/(sici)1099-1050(199809)7:6<481::aid-hec353>3.0.co;2-k · Cited by 273
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
Bytzer, P., Hansen, J. M., & Schaffalitzky de Muckadell, O. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92023-0 · Cited by 252
(2001) · New England Journal of Medicine · doi:10.1056/nejm200111153452023 · Cited by 238
Some guidelines on the use of cost effectiveness league tables.
Mason, J., Drummond, M., & Torrance, G. (1993) · BMJ · doi:10.1136/bmj.306.6877.570 · Cited by 220
Self-citationStrained Mercy: The Economics of Canadian Health Care
Vayda, E., & Evans, R. G. (1985) · Journal of Public Health Policy · doi:10.2307/3342054 · Cited by 212
The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment
Sculpher, M., Drummond, M., & Buxton, M. (1997) · Journal of Health Services Research & Policy · doi:10.1177/135581969700200107 · Cited by 208
Self-citationCost effectiveness of community leg ulcer clinics: randomised controlled trial
Morrell, C. J., Walters, S. J., Dixon, S., Collins, K. A., Brereton, L. M. L., Peters, J., & Brooker, C. G. D. (1998) · BMJ · doi:10.1136/bmj.316.7143.1487 · Cited by 202
GARCÍA, M. S., CAMBRONERO GALACHE, J. A., DIAZ, J. L., CERDÁ, E. C., BLASCO, J. R., GÓMEZ AGUINAGA, M. A., REIZ, A. N., MARÍN, S. R., OÑORO CAÑAVERAL, J. J., & SACRISTÁN del CASTILLO, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9712079 · Cited by 199
Collinson, J. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1995 · Cited by 198
Pedersen, T. R., Kjekshus, J., Berg, K., Olsson, A. G., Wilhelmsen, L., Wedel, H., Pyörälä, K., Miettinen, T., Haghfelt, T., Færgeman, O., et al. (1996) · Circulation · doi:10.1161/01.cir.93.10.1796 · Cited by 197
Multilevel models and health economics
Rice, N., & Jones, A. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199711)6:6<561::aid-hec288>3.0.co;2-x · Cited by 190
A Multilevel Analysis of School Examination Results
Goldstein, H., Rasbash, J., Yang, M., Woodhouse, G., Pan, H., Nuttall, D., & Thomas, S. (1993) · Oxford Review of Education · doi:10.1080/0305498930190401 · Cited by 182
Guthrie, E. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.519 · Cited by 180
Jonsson, B., Johannesson, M., Kjekshus, J., Olsson, A. G., Pedersen, T. R., Wedel, H., & Scandlnavlan Simvastatin Survival Study Group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014994 · Cited by 176
Friedman, M., Serby, C. W., Menjoge, S. S., Wilson, J. D., Hilleman, D. E., & Witek, T. J. (1999) · Chest · doi:10.1378/chest.115.3.635 · Cited by 175
Mark, D. B., Cowper, P. A., Berkowitz, S. D., Davidson-Ray, L., DeLong, E. R., Turpie, A. G. G., Califf, R. M., Weatherley, B., & Cohen, M. (1998) · Circulation · doi:10.1161/01.cir.97.17.1702 · Cited by 171
Reducing Maternal Smoking and Relapse: Long-Term Evaluation of a Pediatric Intervention
Severson, H. H., Andrews, J. A., Lichtenstein, E., Wall, M., & Akers, L. (1997) · Preventive Medicine · doi:10.1006/pmed.1996.9983 · Cited by 165
McClellan, M. (1994) · JAMA · doi:10.1001/jama.272.11.859 · Cited by 163
Issues in the Cross-National Assessment of Health Technology
Drummond, M. F., Bloom, B. S., Carrin, G., Hillman, A. L., Hutchings, H. C., Knill-jones, R. P., De Pouvourville, G., & Torfs, K. (1992) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300002361 · Cited by 160
Self-citationHughes, D. A., Bagust, A., Haycox, A. R., & Walley, T. (2001) · Health Economics · doi:10.1002/hec.609 · Cited by 158
Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation
Grunfeld, E., Gray, A. M., Mant, D., Yudkin, P. L., Adewuyi-Dalton, R., Coyle, D., Cole, D., Stewart, J., Fitzpatrick, R. M., & Vessey, M. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690197 · Cited by 149
Grossman, R. F., Mukherjee, J., Vaughan, D., Eastwood, C., Cook, R. J., LaForge, J., & Lampron, N. (1998) · CHEST Journal · doi:10.1378/chest.113.1.131 · Cited by 146
Briggs, A. H., Mooney, C. Z., & Wonderling, D. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991215)18:23<3245::aid-sim314>3.0.co;2-2 · Cited by 146
Equity and the economic evaluation of healthcare
Sassi, F., Archard, L., & Grand, J. L. (2001) · Health Technology Assessment · doi:10.3310/hta5030 · Cited by 142
Meta-Analysis Using Multilevel Models with an Application to the Study of Class Size Effects
Goldstein, H., Yang, M., Omar, R., Turner, R., & Thompson, S. G. (2000) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00200 · Cited by 141
Ellis, S. L., Carter, B. L., Malone, D. C., Billups, S. J., Okano, G. J., Valuck, R. J., Barnette, D. J., Sintek, C. D., Covey, D. F., Mason, B. J., et al. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1508.34852 · Cited by 139
Cost-effectiveness of captopril therapy after myocardial infarction
Tsevat, J., Duke, D., Goldman, L., Pfeffer, M. A., Lamas, G. A., Soukup, J. R., Kuntz, K. M., & Lee, T. H.-Y. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00284-1 · Cited by 127
Integrated care for asthma: a clinical, social, and economic evaluation
Drummond, N., Abdalla, M., Buckingham, J. K., Beattie, J. A. G., Lindsay, T., Osman, L. M., Ross, S., Roy-Chaudhury, A., Russell, I. T., Turner, M. E., et al. (1994) · BMJ · doi:10.1136/bmj.308.6928.559 · Cited by 121
O'Brien, B., Levine, M., Willan, A., Goeree, R., Haley, S., Blackhouse, G., & Gent, M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.19.2298 · Cited by 121
Franz, M., Splett, P., Monk, A., Barry, B., McClain, K., Weaver, T., Upham, P., Bergenstal, R., & Mazze, R. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00277-4 · Cited by 116
Liem, M. S. L., Halsema, J. A. M., van der Graaf, Y., Schrijvers, G., & van Vroonhoven, T. J. M. V. (1997) · Annals of Surgery · doi:10.1097/00000658-199712000-00004 · Cited by 110
Cost-Effectiveness of Hormone Replacement Therapy in the Menopause
Weinstein, M. C., & Schiff, I. (1983) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198308000-00001 · Cited by 109
Mark, D. B., Harrington, R. A., Lincoff, A. M., Califf, R. M., Nelson, C. L., Tsiatis, A. A., Buell, H., Mahaffey, K. W., Davidson-Ray, L. D., & Topol, E. J. (2000) · Circulation · doi:10.1161/01.cir.101.4.366 · Cited by 109
Ades, A. E., & Cliffe, S. (2002) · Medical Decision Making · doi:10.1177/027298902400448920 · Cited by 104
Sharp, S. J., & Thompson, S. G. (2000) · Statistics in Medicine · Cited by 102
The Evidence Base on the Cost-Effectiveness of Malaria Control Measures in Africa
Goodman, C. A., & MILLS, A. J. (1999) · Health Policy and Planning · doi:10.1093/heapol/14.4.301 · Cited by 101
Resource costing for multinational neurologic clinical trials: methods and results
Schulman, K. A., Burke, J. E., Drummond, M., Davies, L. M., Carlsson, P., Gruger, J., Harris, A., Lucioni, C., Gisbert, R., Llana, T., et al. (1998) · Health Economics · doi:10.1002/(sici)1099-1050(1998110)7:7<629::aid-hec378>3.0.co;2-n · Cited by 98
Self-citationCost-Effectiveness of a Hospital-Based Smoking Cessation Intervention
Meenan, R. T., Stevens, V. J., Hornbrook, M. C., Chance, P.-A. L., Glasgow, R. E., Hollis, J. F., Lichtenstein, E. H., & VOGT, T. M. (1998) · Medical Care · doi:10.1097/00005650-199805000-00007 · Cited by 98
Sculpher, M. J., Buxton, M. J., Seed, P. T., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92274-8 · Cited by 95
Self-citationThe Confidence Profile Method: A Bayesian Method for Assessing Health Technologies
Eddy, D. M. (1989) · Operations Research · doi:10.1287/opre.37.2.210 · Cited by 93
Kald, A., Anderberg, B., Carlsson, P., Park, P.-O., & Smedh, K. (1997) · PubMed · Cited by 92
The marginal cost-effectiveness of medical technology: A panel instrumental-variables approach
McClellan, M., & Newhouse, J. P. (1997) · Journal of Econometrics · doi:10.1016/s0304-4076(96)01805-2 · Cited by 90
The Advanced Handbook of Methods in Evidence Based Healthcare
Stevens, A. J., Abrams, K., Brazier, J. E., Fitzpatrick, R. M., & Lilford, R. J. (2001) · SAGE Publications Ltd eBooks · doi:10.4135/9781848608344 · Cited by 88
The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial
Jönsson, B., Cook, J. R., & Pedersen, T. R. (1999) · Diabetologia · doi:10.1007/s001250051441 · Cited by 88
Modelling in economic evaluation
Kuntz, K. M., & Weinstein, M. C. (2001) · Economic Evaluation in Health Care · doi:10.1093/oso/9780192631770.003.0007 · Cited by 87
A randomized, controlled, clinical study of laparoscopic vs open tension-free inguinal hernia repair
Paganini, A. M., Lezoche, E., Carle, F., Carlei, F., Favretti, F., Feliciotti, F., Gesuita, R., Guerrieri, M., Lomanto, D., Nardovino, M., et al. (1998) · Surgical Endoscopy · doi:10.1007/s004649900760 · Cited by 85
A tale of two (or more) cities: geographic transferability of pharmacoeconomic data.
OʼBrien, B. J. (1997) · PubMed · Cited by 82
Harrington, R. (2000) · BMJ · doi:10.1136/bmj.321.7268.1047 · Cited by 80
Assessing the appropriateness of combining economic data from multinational clinical trials
Cook, J. R., Drummond, M., Glick, H. A., & Heyse, J. F. (2003) · Statistics in Medicine · doi:10.1002/sim.1389 · Cited by 75
Self-citationHull, R. D. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440240051008 · Cited by 70
Charnas, R. L., LÜTHI, A. R., & Ruch, W. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199704000-00003 · Cited by 69
The community psychiatric nurse in primary care: an economic analysis
Gournay, K., & Brooking, J. (1995) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1995.22040769.x · Cited by 68
Generalisation from phase III clinical trials: survival, quality of life, and health economics
Fayers, P. M., & Hand, D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03053-5 · Cited by 68
The role and estimation of productivity costs in economic evaluation
Sculpher, M. J. (2001) · doi:10.1093/oso/9780192631770.003.0005 · Cited by 68
Self-citationA randomized controlled trial and economic evaluation of counselling in primary care.
Harvey, I. M., Nelson, S., Lyons, R. A., Unwin, C., Monaghan, S., & Peters, T. J. (1998) · Europe PMC (PubMed Central) · Cited by 67
Bailey, T. C., Ritchie, D. J., McMullin, S. T., Kahn, M. G., Reichley, R. M., Casabar, E., Shannon, W., & Dunagan, W. C. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03710.x · Cited by 67
Jones, R. H., Tait, C., Sladen, G. E., & Weston‐Baker, J. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11765.x · Cited by 66
An exercise on the feasibility of carrying out secondary economic analyses
Jefferson, T., Mugford, M., Gray, A. M., & Demicheli, V. (1996) · Health Economics · Cited by 60
How cost-effective is breast cancer screening in different EC countries?
van Ineveld, B. M., van Oortmarssen, G. J., de Koning, H. J., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90100-t · Cited by 58
Ghatnekar, O., Persson, U., Willis, M. S., & Ödegaard, K. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119070-00005 · Cited by 57
Cost‐Effectiveness of Hormone Replacement
Weinstein, M. C., & Tosteson, A. N. A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30324.x · Cited by 57
The Generalisability of Pharmacoeconomic Studies
Mason, J. M. (1997) · PharmacoEconomics · doi:10.2165/00019053-199711060-00001 · Cited by 56
Hormone replacement therapy in a risk-benefit perspective
Daly, E., Vessey, M. P., Barlow, D., Gray, A. M., McPherson, K., & Roche, M. (1996) · Maturitas · doi:10.1016/0378-5122(95)00978-7 · Cited by 55
The clinical-economic trial: Promise, problems, and challenges
Powe, N. R., & Griffiths, R. I. (1995) · Controlled Clinical Trials · doi:10.1016/s0197-2456(95)00075-5 · Cited by 55
Schulman, K. A., Buxton, M. J., Glick, H. A., Sculpher, M., Guzman, G. I., Kong, J., Backhouse, M. E., Mauskopf, J., Bell, L., & Eisenberg, J. M. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300010989 · Cited by 52
Self-citationAn economic evaluation of laparoscopic versus open inguinal hernia repair
Lawrence, K., McWhinnie, D. L., Goodwin, A., Gray, A. M., Gordon, J., Storie, J., Britton, J., & Collin, J. (1996) · Journal of Public Health · doi:10.1093/oxfordjournals.pubmed.a024460 · Cited by 49
A Multinational Economic Evaluation of rhDNase in the Treatment of Cystic Fibrosis
Menzin, J., Oster, G., Davies, L. M., et al. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300009387 · Cited by 49
Self-citationCost-utility analysis from a societal perspective
Johannesson, M., & O’Conor, R. M. (1997) · Health Policy · doi:10.1016/s0168-8510(96)00878-0 · Cited by 47
Wage differentials across firms: an application of multilevel modelling
Cardoso, A. R. (2000) · Journal of Applied Econometrics · doi:10.1002/1099-1255(200007/08)15:4 · Cited by 46
Neymark, N., Kiebert, W., Torfs, K., Davies, L. M., Fayers, P. M., Hillner, B. E., Gelber, R. D., Guyatt, G. H., Kind, P., Machin, D., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00074-4 · Cited by 46
Self-citationStålhammar, N., Carlsson, J., Peacock, R., Müller-Lissner, S. A., Bigard, M., Porro, G. B., Ponce, J. D. C., Hosie, J., Scott, M. G., Weir, D. G., et al. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916050-00006 · Cited by 46
Geographic Variation in Resource Use for Coronary Artery Bypass Surgery
Cowper, P. A., DeLong, E. R., Peterson, E. D., Lipscomb, J., Muhlbaier, L. H., Jollis, J. G., Pryor, D. B., & Mark, D. B. (1997) · Medical Care · doi:10.1097/00005650-199704000-00004 · Cited by 44
Freeman, H. L. (1984) · Evaluation and Program Planning · doi:10.1016/0149-7189(84)90066-1 · Cited by 43
Oster, G., Huse, D. M., Lacey, M. J., et al. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900501 · Cited by 42
Making cost assessments based on RCTs more useful to decision-makers
Baltussen, R. M. P. M., Ament, A. J. H. A., & Leidl, R. (1996) · Health Policy · doi:10.1016/s0168-8510(96)90023-8 · Cited by 42
The costs of HIV prevention strategies in developing countries.
Soderlund, N., Lavis, J. N., Broomberg, J., & MILLS, A. J. (1993) · Europe PMC (PubMed Central) · Cited by 41
Sacristán, J. A. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00120-8 · Cited by 41
Torrance, G. W., Walker, V., Grossman, R. F., Mukherjee, J., Vaughan, D., Forge, J. L., & Lampron, N. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916050-00007 · Cited by 40
Rosner, A., Grima, D. T., Torrance, G. W., Bradley, C. J., Adachi, J. D., Sebaldt, R. J., & Willison, D. J. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814050-00007 · Cited by 39
Hillman, A. L., Schwartz, J. S., Willian, M. K., Peskin, E., Roehrborn, C. G., Oesterling, J. E., Mason, M. E., Maurath, C. J., Deverka, P. A., & Padley, R. J. (1996) · Urology · doi:10.1016/s0090-4295(99)80410-5 · Cited by 38
Rajan, R., Gafni, A., Levine, M. N., et al. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.42 · Cited by 37
Economic evaluation alongside cancer trials: Methodological and practical aspects
Bonsel, G. J., Rutten, F., & Groot, C. A. U.-D. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90610-r · Cited by 37
Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
Mölken, M. R., van Doorslaer, E. K. A., & Till, M. D. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814060-00007 · Cited by 36
Oster, G., Borok, G. M., Menzin, J., Heyse, J. F., Epstein, R. S., Quinn, V. P., Benson, V. M., Dudl, R. J., & Epstein, A. M. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00028-2 · Cited by 35
Sculpher, M. J., Poole, L., Cleland, J. G. F., Drummond, M., Armstrong, P. W., Horowitz, J. D., Massie, B. M., Poole-Wilson, P. A., & Rydén, L. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00122-7 · Cited by 33
Self-citationEconomic Analysis in Phase III Clinical Cancer Trials
Bennett, C. L., Armitage, J. L., Buchner, D. A., & Gulati, S. C. (1994) · Cancer Investigation · doi:10.3109/07357909409023033 · Cited by 31
Simpson, K. N., Hatziandreu, E. J., Andersson, F., Shakespeare, A., Oleksy, I., & Tosteson, A. N. A. (1994) · PharmacoEconomics · doi:10.2165/00019053-199406060-00008 · Cited by 31
Perimenopausal bone density screening—will it help prevent osteoporosis?
Garton, M. J., Cooper, C. C., & Reid, D. M. (1997) · Maturitas · doi:10.1016/s0378-5122(96)01079-1 · Cited by 29
Fagnani, F., Bouvenot, G., Valat, J., Bardin, T., Berdah, L., Lafuma, A. J., Bono, I., Eschwege, E., & Dreiser, R.-L. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813010-00013 · Cited by 29
Data Collection Methods in Prospective Economic Evaluations: How Accurate Are the Results?
Evans, C. J., & Crawford, B. (2000) · Value in Health · doi:10.1046/j.1524-4733.2000.34005.x · Cited by 29
The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure
Dasbach, E. J., Rich, M. W., Segal, R., Gerth, W. C., Carides, G. W., Cook, J. R., Murray, J. F., Snavely, D. B., & Pitt, B. (1999) · Cardiology · doi:10.1159/000006908 · Cited by 28
Sullivan, S. D., Liljas, B., Buxton, M. J., Lamm, C. J., O’Byrne, P. M., Tan, W. C., & Weiss, K. B. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00137-4 · Cited by 28
The impact of age on cost-effectiveness ratios and its control in decision making
Baltussen, R. M. P. M., Leidl, R., & Ament, A. J. H. A. (1996) · Health Economics · Cited by 27
Robinson, M., Ginnelly, L., Sculpher, M., Jones, L., Riemsma, R. P., Palmer, S., Phillips, Z., & Glanville, J. (2002) · Health Technology Assessment · doi:10.3310/hta6250 · Cited by 26
Self-citationGlick, H. A., Willke, R. J., Polsky, D. E., Llana, T., Alves, W. M., Kassell, N. F., & Schulman, K. A. (1998) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646230001059x · Cited by 23
Cost-effectiveness of a delayed pushing policy for patients with epidural anesthesia
Petrou, S., Coyle, D., & Fraser, W. D. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.104213 · Cited by 22
Jonghe, E. D., Murray, C. J. L., Chum, H. J., Nyangulu, D. S., Salomão, A. L. S. J., & Styblo, K. (1994) · The International Journal of Health Planning and Management · doi:10.1002/hpm.4740090204 · Cited by 22
Methodological Hurdles in Conducting Pharmacoeconomic Analyses
Douglasrizzo, J., & Powe, N. R. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915040-00002 · Cited by 20
Finnish Healthy Village Study: impact and outcomes of a low-cost local health promotion programme
Kumpusalo, E. A., Neittaanmäki, L., Halonen, P. M., Pekkarinen, H., Penttilä, I., & Parviainen, M. T. (1996) · Health Promotion International · doi:10.1093/heapro/11.2.105 · Cited by 17
Diagnostic laparoscopic cholecystectomy
Spiro, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90221-n · Cited by 16
White, D., Billingham, L. J., Chapman, S., Drake, S., Jayaweera, D. T., Jones, S., Opaneye, A. A., & Temple, C. (1997) · Sexually Transmitted Infections · doi:10.1136/sti.73.3.184 · Cited by 15
Laloux, P., Vakaet, A., Monseu, G., Jacquy, J., Bourgeois, P., & van der Linden, C. (1998) · PubMed · Cited by 13
Small, Blue Collar Work Site Hypertension Screening: A Cost-Effectiveness Study
Ellis, E., Koblin, W., Irvine, M. J., Legare, J., & Logan, A. G. (1994) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199403000-00013 · Cited by 13
What to Consider When Conducting a Cost-Effectiveness Analysis in a Clinical Setting
Naglak, M. C., Mitchell, D. C., Kris‐Etherton, P. M., HARKNESS, W., & Pearson, T. A. (1998) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(98)00266-1 · Cited by 10
Stason, W. B. (1990) · Springer eBooks · doi:10.1007/978-3-642-75781-5_3 · Cited by 6
Clinical Trials and External Validity
Kinosian, B. P., & Glick, H. A. (1998) · Value in Health · doi:10.1046/j.1524-4733.1998.130181.x · Cited by 4
Cited by
Exercise-based cardiac rehabilitation for coronary heart disease
Heran, B. S., Chen, J. M., Ebrahim, S., Moxham, T., Oldridge, N., Rees, K., Thompson, D. R., & Taylor, R. S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001800.pub2 · Cited by 1,844
Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension
Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., Brundage, M. D., & CONSORT PRO Group, F. T. (2013) · JAMA · doi:10.1001/jama.2013.879 · Cited by 1,386
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Home-based versus centre-based cardiac rehabilitation
Taylor, R. S., Dalal, H., Jolly, K., Moxham, T., & Zawada, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007130.pub2 · Cited by 623
A taxonomy of model structures for economic evaluation of health technologies
Brennan, A., Chick, S. E., & Davies, R. (2006) · Health Economics · doi:10.1002/hec.1148 · Cited by 555
Metadata
- Authors
- Sculpher, M., Pang, F., Manca, A., Drummond, M., Golder, S., Urdahl, H., Davies, L., & Eastwood, A.
- Venue
- Health Technology Assessment
- Published
- 2004-12
- Volume
- 8
- Issue
- 49
- Pages
- iii-iv, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1972388955
- Cited by
- 441
- References
- 145
- FWCI
- 49.78
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.